T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.
Ilaria Schiavoni, Annapina Palmieri, Eleonora Olivetta and 10 others
PMID 36587928WHAT IT FOUND
In 34 nursing home residents, overall spike-specific T-cell response was similar before and after a booster, while antibody levels were higher and T-cell increases were clearer in residents without prior infection.
Key findings
01Among 34 residents, 31 had a positive spike-specific T-cell response before the booster and 28 had one after the booster, with no significant change in overall magnitude.
02At the postbooster sample, the geometric mean anti-spike IgG was 4397 BAU/mL, compared with 892 BAU/mL at the prebooster sample.
03Residents without prior SARS-CoV-2 infection showed clearer T-cell increases after the booster, while residents with prior infection had stronger T-cell responses before the booster.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The final analysis included 34 of the initial 51 residents because some died, were discharged or transferred, were excluded for active infection, or had too few cells to test. The study had no control group, so it cannot show how much the booster changed immunity compared with no booster. Residents with prior infection and naïve residents followed different vaccination schedules, so the groups are not directly comparable. The sample was small, and the authors note that subgroup comparisons were too small to demonstrate booster effects on polyfunctional T cells. The outcomes were antibody and T-cell measurements, not infection, severe disease, hospitalization, or death. The study measured immunity to ancestral spike protein, and the authors say protection against SARS-CoV-2 variants still needs assessment.
Declared interests
The supplied text does not report specific funders or author conflicts of interest. The publication types note research support from non-U.S. government.
The easy way to misread this
Do not read higher antibody levels as proof that the booster prevents infection or severe disease in nursing home residents. The overall T-cell response was similar before and after the booster, the study had no control group, and it measured immune markers rather than clinical outcomes.